Larimar Therapeutics's total assets for Q1 2025 were $170.18M, a decrease of -15.01% from the previous quarter. LRMR total liabilities were $25.90M for the fiscal quarter, a -8.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.